Glaukos Corp (GKOS)
158.12
+1.52
(+0.97%)
USD |
NYSE |
Jan 08, 16:00
158.07
-0.05
(-0.03%)
After-Hours: 20:00
Glaukos Research and Development Expense (Annual): 138.77M for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Globus Medical Inc | 124.01M |
| Abbott Laboratories | 2.741B |
| Boston Scientific Corp | 1.414B |
| Intuitive Surgical Inc | 998.80M |
| Masimo Corp | 175.20M |